Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Still no PR on Markman results.

I'm afraid you misunderstood Cliff re: PR release. IMO, they HAVE TO issue a PR/8-K TODAY to satisfy SEC reporting requirements.

SGE

Share
New Message
Please login to post a reply